| DC Field | Value | Language |
|---|
| dc.contributor.author | Anufrieva, E. I. | - |
| dc.contributor.author | Popov, S. S. | - |
| dc.contributor.author | Krylskii, E. D. | - |
| dc.contributor.author | Verevkin, A. N. | - |
| dc.contributor.author | Bolotskih, V. I. | - |
| dc.contributor.author | Sviridov, D. V. | - |
| dc.date.accessioned | 2026-10-12T13:29:33Z | - |
| dc.date.available | 2026-10-12T13:29:33Z | - |
| dc.date.issued | 2026 | - |
| dc.identifier.citation | The effect of methylethylpyridinol hydrochloride on the levels of α-tocopherol and transforming growth factor β-1 in patients with chronic kidney disease and type 2 diabetes mellitus / E.I. Anufrieva, S.S. Popov, E.D. Krylskii [et al.] // Research Results in Pharmacology. - 2026. - Vol.12, №1.-P. 48-55. - DOI: 10.18413/rrpharmacology.12.763. - Refer.: p. 54-55. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/67096 | - |
| dc.description.abstract | The aim of the research was to assess the levels of α-tocopherol and TGF-β1 in individuals with CKD and type 2 DM who were undergoing standard treatment and treatment with methylethylpyridinol hydrochloride | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | methylethylpyridinol hydrochloride | ru |
| dc.subject | oxidative stress | ru |
| dc.subject | type 2 diabetes mellitus | ru |
| dc.subject | chronic kidney disease | ru |
| dc.subject | α-tocopherol | ru |
| dc.title | The effect of methylethylpyridinol hydrochloride on the levels of α-tocopherol and transforming growth factor β-1 in patients with chronic kidney disease and type 2 diabetes mellitus | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 12, № 1
|
